StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report released on Thursday. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their price objective on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
Get Our Latest Analysis on SenesTech
SenesTech Stock Down 2.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- Top Stocks Investing in 5G Technology
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Best Aerospace Stocks Investing
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.